Researchers at the Andrews Institute for Orthopedics and Sports Medicine are working on a breakthrough clinical trial that could soon bring FDA approval for stem cell knee cartilage repair that’s already available in other countries. Dr. Khay Yong Saw, from Kuala Lumpur, has developed this effective treatment to inject autologous (the patient’s own) stem cells into the deteriorated cartilage to restore its previous durability and function. He is now supervising the process in hopes that his methods can be adapted in an FDA approved treatment. The treatment has the potential to replace invasive surgical procedures that require months in postoperative recovery, and could even utilize mesenchymal stem cells (the same ones found in teeth) given their known properties of differentiating into cartilage tissue. This treatment has already shown promise with over 700 patients in Malaysia in the last 5 years.
Dr. Adam Anz, head of the project at the Andrews Institute states, “In my mind there was a paradigm shift in thinking about how can we get cells in our bodies and use those in the least invasive way to help with injury and recovery.”
The Andrews Institute’s innovative research demonstrates the integral role stem cells are playing in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies soon. To learn more about banking stem cells, please visit StemSave or call 877-783- 6728 (877-StemSave) today.
The Future of Regenerative Medicine is Now™
To view the full article, click here.